CHRISTOPHER ALBRIGHT: Open Payments
NPI 1609401728 · NORTHPORT, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,512 in 96 payments from 22 companies in 2025. Trend: 2023 $1,559 · 2024 $1,544 · 2025 $1,512
Food & beverage: $1,512
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $226 |
| Novo Nordisk Inc | 15 | $213 |
| Lilly USA, LLC | 12 | $186 |
| PFIZER INC. | 10 | $153 |
| Corium, LLC | 7 | $134 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $111 |
| AstraZeneca Pharmaceuticals LP | 6 | $87 |
| Ferring Pharmaceuticals Inc. | 2 | $79 |
| Antares Pharma, Inc. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
Products named: Azstarys, Ozempic, MOUNJARO, Kerendia, NURTEC ODT, OTEZLA, KRYSTEXXA, Wegovy.
Industry payments across AL — which companies pay providers there.
